Fig. 3From: CAR-T bridging to allo-HSCT as a treatment strategy for relapsed adult acute B-lymphoblastic leukemia: a case reportChanges within 28 days following CAR-T cell infusion in the body: a Body temperature; b C-reactive protein levels; c Number of lymphoblasts in the bone marrowBack to article page